A potential candidate to explain these findings is therefore FVIIa, which would form a TF:FVIIa complex on the surface of tumour cells in vivo leading to the activation of type-2 proteinase activated receptor-dependent signalling (Ruf, 2007). The gene discussed is TF; the disease is neoplasm.